[The effect of a beta-adrenergic blocking agent on driving capability (author's transl)].

The effect of Betadrenol, a beta-adrenergic blocking agent, was studied by means of traffic psychology tests in 29 male patients with cardiovascular disorders. The age range was 29 to 60 years. After a 7-day wash-out period, each subject received either 3 x 100 mg Betadrenol or a placebo daily during three days. Subsequently every patient was given 3 x 100 mg of Betadrenol daily during another ten days. The short-term double-blind study revealed no impairment of driving performance. The results of the open study showed significant improvements, especially in concentration and speed of reaction.

RCT Entities:   Population Interventions Outcomes